March 2018

Cure SMA Awards $75,000 Grant to Robert Kalb, MD, Northwestern University

Cure SMA has awarded a $75,000 research grant to Robert Kalb, MD, at Northwestern University Feinberg School of Medicine, for his project, “Effects of diminished SMN on segmental spinal cord innervation of motor neurons.” Dr. Kalb and his team have conducted studies that indicate that there are abnormal connections to motor neurons in their worm […]

Cure SMA Awards $75,000 Grant to Robert Kalb, MD, Northwestern University Read More »

Cure SMA to Host Inaugural Clinical Care Meeting

Clinicians across the country are invited to share experiences, successes and ideas at the inaugural SMA Clinical Care Meeting to be held on Saturday, June 16, 2018 at the 2018 Annual SMA Conference in Dallas, Texas. As Spinraza and future FDA-approved treatments extend the lives of those with SMA, care has become even more important. Our

Cure SMA to Host Inaugural Clinical Care Meeting Read More »

Cure SMA Awards $150,000 Grant to Umrao Monani, PhD, Columbia University

Cure SMA has awarded a $150,000 research grant to Umrao Monani, PhD, at Columbia University, for his project, “SMA modulators as a means to revealing disease mechanisms.” Dr. Monani and his team have generated SMA model mice and shown that their genetic background can alter disease severity. By studying these mice, they have identified two

Cure SMA Awards $150,000 Grant to Umrao Monani, PhD, Columbia University Read More »

Biogen Announces New Interim Phase 2 Results From NURTURE

Biogen recently announced new interim Phase 2 results from NURTURE, the ongoing open-label, single-arm study evaluating the efficacy and safety of SPINRAZA or nusinersen among pre-symptomatic infants with spinal muscular atrophy. Additionally, data from a case series conducted on SPINRAZA-treated teens and young adults was also released. The main findings of which are summarized below:

Biogen Announces New Interim Phase 2 Results From NURTURE Read More »

Cure SMA Launches Second Annual Community Survey to Address Important Issues in SMA Treatment

Dear Members of the SMA Community, For the past several years, we’ve been working to collect data and information on our community’s experiences, goals, hopes, and challenges. We know that the voice of our community is powerful. By sharing our stories, we can communicate our priorities to the FDA and regulators, provide insight into daily

Cure SMA Launches Second Annual Community Survey to Address Important Issues in SMA Treatment Read More »

Indiana is the Fourth State to Adopt Permanent SMA Screening

Last night, Governor Eric Holcomb of Indiana signed HB 1017, adding spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) to the state’s newborn screening panel. The bill makes Indiana the fourth state in the country to adopt permanent SMA screening, following Missouri, Utah and Minnesota. The legislation was sponsored by Representative Doug Gutwein, and

Indiana is the Fourth State to Adopt Permanent SMA Screening Read More »

Cure SMA Awards $150,000 Grant to Allison Ebert, PhD, Medical College of Wisconsin

Cure SMA has awarded a $150,000 research grant to Allison Ebert, PhD, at the Medical College of Wisconsin, for her project, “Role of astrocyte-produced miR-146a in SMA pathology.” SMA is caused by mutations in the SMN1 gene resulting in low levels of SMN protein, which is expressed in every cell in the body. The goal

Cure SMA Awards $150,000 Grant to Allison Ebert, PhD, Medical College of Wisconsin Read More »

Cure SMA Welcomes New Medical Advisory Council Committee Members

We are excited to welcome 20 new members to our Medical Advisory Council (MAC). These clinicians represent eleven specialties, including specialties that were not previously represented on the MAC. Our new members are: Alison Ballard, RN, MSN, Pediatric Nurse Practitioner and Neuromuscular Care Coordinator at Children’s Hospital Colorado in Denver, CO  William Bell, BS Pharm,

Cure SMA Welcomes New Medical Advisory Council Committee Members Read More »

Scroll to Top